These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 38357951)
1. The Role of NAD Pei Z; Yang C; Guo Y; Dong M; Wang F Curr Pharm Biotechnol; 2024; 25(17):2300-2311. PubMed ID: 38357951 [TBL] [Abstract][Full Text] [Related]
2. Combination of LCZ696 and ACEI further improves heart failure and myocardial fibrosis after acute myocardial infarction in mice. Liu Y; Fan Y; Li J; Chen M; Chen A; Yang D; Guan X; Cao Y Biomed Pharmacother; 2021 Jan; 133():110824. PubMed ID: 33378988 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy. von Lueder TG; Wang BH; Kompa AR; Huang L; Webb R; Jordaan P; Atar D; Krum H Circ Heart Fail; 2015 Jan; 8(1):71-8. PubMed ID: 25362207 [TBL] [Abstract][Full Text] [Related]
4. LCZ696 Therapy Reduces Ventricular Tachyarrhythmia Inducibility in a Myocardial Infarction-Induced Heart Failure Rat Model. Chang PC; Lin SF; Chu Y; Wo HT; Lee HL; Huang YC; Wen MS; Chou CC Cardiovasc Ther; 2019; 2019():6032631. PubMed ID: 31772612 [TBL] [Abstract][Full Text] [Related]
5. Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats. Raj P; Sayfee K; Parikh M; Yu L; Wigle J; Netticadan T; Zieroth S Molecules; 2021 Aug; 26(16):. PubMed ID: 34443591 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction. Kompa AR; Lu J; Weller TJ; Kelly DJ; Krum H; von Lueder TG; Wang BH Int J Cardiol; 2018 May; 258():192-198. PubMed ID: 29544929 [TBL] [Abstract][Full Text] [Related]
7. Endostatin attenuates heart failure via inhibiting reactive oxygen species in myocardial infarction rats. Xu X; Jiang T; Li Y; Kong L Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 32686821 [TBL] [Abstract][Full Text] [Related]
8. Sacubitril/valsartan (LCZ696) reduces myocardial injury following myocardial infarction by inhibiting NLRP3‑induced pyroptosis via the TAK1/JNK signaling pathway. Shen J; Fan Z; Sun G; Qi G Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296299 [TBL] [Abstract][Full Text] [Related]
9. [Change of short-chain acyl-CoA dehydrogenase in heart failure after myocardial infarction in rats and the intervention of aerobic exercise]. Liao Y; Li Z; Shu Z; Zhong X; Su Y; Ma Z; Liu P; Lu J; Zang L; Pan X; Zhou S Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Feb; 31(2):172-177. PubMed ID: 30827304 [TBL] [Abstract][Full Text] [Related]
10. Effect of Neprilysin Inhibition for Ischemic Mitral Regurgitation after Myocardial Injury. Lee S; Hwang HS; Song N; Kang GH; Choi KH; Ji E; Song JM; Kang DH Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445301 [TBL] [Abstract][Full Text] [Related]
11. A new model of congestive heart failure in rats. Chen J; Chemaly ER; Liang LF; LaRocca TJ; Yaniz-Galende E; Hajjar RJ Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H994-1003. PubMed ID: 21685270 [TBL] [Abstract][Full Text] [Related]
12. LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice. Suematsu Y; Miura S; Goto M; Matsuo Y; Arimura T; Kuwano T; Imaizumi S; Iwata A; Yahiro E; Saku K Eur J Heart Fail; 2016 Apr; 18(4):386-93. PubMed ID: 26749570 [TBL] [Abstract][Full Text] [Related]
13. Combined levosimendan and Sacubitril/Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat. Sung PH; Chai HT; Yang CC; Chiang JY; Chen CH; Chen YL; Yip HK Biomed Pharmacother; 2022 Apr; 148():112745. PubMed ID: 35202913 [TBL] [Abstract][Full Text] [Related]
14. Effect of LCZ696, a dual angiotensin receptor neprilysin inhibitor, on isoproterenol-induced cardiac hypertrophy, fibrosis, and hemodynamic change in rats. Miyoshi T; Nakamura K; Miura D; Yoshida M; Saito Y; Akagi S; Ohno Y; Kondo M; Ito H Cardiol J; 2019; 26(5):575-583. PubMed ID: 29718530 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin Receptor Neprilysin Inhibitor Attenuates Myocardial Remodeling and Improves Infarct Perfusion in Experimental Heart Failure. Pfau D; Thorn SL; Zhang J; Mikush N; Renaud JM; Klein R; deKemp RA; Wu X; Hu X; Sinusas AJ; Young LH; Tirziu D Sci Rep; 2019 Apr; 9(1):5791. PubMed ID: 30962467 [TBL] [Abstract][Full Text] [Related]
17. Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure. Odiete O; Konik EA; Sawyer DB; Hill MF Cardiovasc Diabetol; 2013 Mar; 12():52. PubMed ID: 23530877 [TBL] [Abstract][Full Text] [Related]
18. Effect of Renal Denervation on Cardiac Function and Inflammatory Factors in Heart Failure After Myocardial Infarction. Li C; Xia W; Wang L; Zhang J; He Q; Liu Y; Xia D; Lu C J Cardiovasc Pharmacol; 2020 Nov; 76(5):602-609. PubMed ID: 32868626 [TBL] [Abstract][Full Text] [Related]
19. Sacubitril Valsartan Enhances Cardiac Function and Alleviates Myocardial Infarction in Rats through a SUV39H1/SPP1 Axis. Shen JF; Fan ZB; Wu CW; Qi GX; Cao QY; Xu F Oxid Med Cell Longev; 2022; 2022():5009289. PubMed ID: 36193085 [TBL] [Abstract][Full Text] [Related]
20. [Sacubitril/valsartan attenuates left ventricular remodeling and improve cardiac function by upregulating apelin/APJ pathway in rats with heart failure]. Liu HZ; Gao CY; Yuan F; Xu Y; Tian H; Wang SQ; Zhang PF; Shi YN; Wei JJ Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jul; 50(7):690-697. PubMed ID: 35856226 [No Abstract] [Full Text] [Related] [Next] [New Search]